openPR Logo
Press release

Human Milk Oligosaccharides (HMO) Market to Reach USD 484.25 Million by 2032, Driven by Growing Demand for Infant Formula and Benefits in Infant Nutrition

05-09-2023 03:11 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Reports and Data

The global Human Milk Oligosaccharides (HMO) market has been witnessing significant growth in recent years, and is projected to continue to do so in the coming decade. According to data, the market size was valued at USD 143.16 Million in 2022 and is expected to reach USD 484.25 Million in 2032, registering a CAGR of 14.5% during the forecast period. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, rising demand for infant formula, and growing awareness about the benefits of human milk oligosaccharides in infant nutrition.

Human milk oligosaccharides are complex sugars found in human breast milk that are not digestible by infants, but play a crucial role in developing an infant's immune system and gut health. However, the high cost and limited availability of human milk oligosaccharides have led to the development of alternative sources, such as cow's milk and yeast-based human milk oligosaccharides. These alternatives are gaining popularity due to their comparable efficacy and lower cost.

HMOs are known to improve the immune system and gut health of infants, and help in reducing the risk of infections, allergies, and other diseases. This has led to the inclusion of human milk oligosaccharides in various infant formula products, which is driving the revenue growth of the market. Moreover, the rising demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements. In conclusion, the market for Human Milk Oligosaccharides is expected to experience significant growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, rising demand for infant formula, and growing awareness about the benefits of human milk oligosaccharides in infant nutrition. With the development of alternative sources of HMOs, the market is expected to become more accessible, making these important nutritional components available to a wider range of consumers.

Request a sample Report of Human Milk Oligosaccharides (HMO) Market @ https://www.reportsanddata.com/download-free-sample/1303

Key Players covered in this report are:

NV, ELICITYL SA, Chr. Hansen Holding A/S, Glycom A/S, Abbott, ZuChem Inc., Glycosyn, Inc., Dextra Laboratories, DuPont (Nutrition & Biosciences), and FrieslandCampina.

Human Milk Oligosaccharides (HMO) Market : Notable Innovation

The Human Milk Oligosaccharides (HMO) market has been witnessing significant innovation in recent years, as companies strive to develop new and effective sources of these complex sugars. One notable innovation in this market has been the use of genetic engineering to produce HMOs in large quantities.

Through genetic engineering, scientists can manipulate the DNA of bacteria to produce HMOs that are structurally identical to those found in human breast milk. This approach has several advantages over traditional methods of producing HMOs, such as extraction from human breast milk or cow's milk.

For one, genetic engineering allows for the production of large quantities of HMOs at a lower cost, making them more accessible to a wider range of consumers. Additionally, this method ensures that the HMOs produced are of a consistent quality and purity, which can be difficult to achieve with other methods.

Some companies are also exploring the use of plant-based sources to produce HMOs. For example, researchers have identified a particular type of sugar molecule found in rice that is structurally similar to HMOs. By isolating and purifying this molecule, it can be used as a source of HMOs.

Another notable innovation in the HMO market is the development of prebiotic supplements that contain HMOs. These supplements are designed to support the growth of beneficial bacteria in the gut, which can help to improve immune function and reduce the risk of various diseases. Some of these supplements are specifically formulated for infants and young children, while others are targeted at adults.

To Know More About the Report @ https://www.reportsanddata.com/report-detail/human-milk-oligosaccharides-hmo-market

Product Outlook (Revenue, USD Billion; 2019-2032)

Fucosyllactose
Sialyllactose
Lacto-N-Tetraose
Lacto-N-Neotetraose

Application Outlook (Revenue, USD Billion; 2019-2032)

Functional Food & Beverages
Infant Formula
Food Supplements
Others

Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)

Hypermarkets & Supermarkets
Drug Store or Pharmacy
Mass Merchandiser
Departmental Stores
Mono-Brand Stores
Specialty Stores
Online Sales Channels

Key Regional Markets Covered in the Report:

North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Explore Latest Research Report by Reports and Data:

Hair Care Market @ https://www.marketwatch.com/press-release/hair-care-market-to-reflect-tremendous-growth-potential-with-a-cagr-of-48-by-2032-2023-04-18?mod=search_headline

Food Safety Testing Market @ https://www.marketwatch.com/press-release/food-safety-testing-market-analysis-to-2030-biggest-driving-factors-for-industry-growth-2023-04-18?mod=search_headline

Gelatin Market @ https://www.marketwatch.com/press-release/gelatin-market-is-moving-towards-with-tremendous-growth-by-2030-2023-04-18?mod=search_headline

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Milk Oligosaccharides (HMO) Market to Reach USD 484.25 Million by 2032, Driven by Growing Demand for Infant Formula and Benefits in Infant Nutrition here

News-ID: 3047118 • Views:

More Releases from Reports and Data

U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billion by 2034, Transforming National Transportation
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility. Market Drivers Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Driven by Sustainability and Cost Efficiency
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies. Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490 Passenger vehicles remain the largest segment of
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Driven by EV Boom and Emission Standards
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations. Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489 Electric and
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies. Electric vehicles (EVs) are the main driver behind this surge, as

All 5 Releases


More Releases for HMO

Human Milk Oligosaccharides (HMO) Market Share $332.6Million by 2028
According to a new report published by Allied Market Research, titled, "Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2028,"the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028. Get a Sample PDF Report to understand our report before
HMO Letting Agent Offers Comprehensive Guide on Finding Ideal HMO Properties
Image: https://lh7-us.googleusercontent.com/docsz/AD_4nXdeRv4NIF32OiXWyCk_Lgr-98A3ijzyBNqao0HtbwwKuAho9YNawZy2S1kszKE2N-k57rQrpogntqzJs2e8E6rcg2-3TToSnnOTitaEQnVfVwBF2yWUymqyLN8z5cTcDB2LHdA5ZVXm9usRTJtfDvkJvjO8?key=7pbbAt0GXq4x8JdfD2bfWw If you're considering investing in property, HMO (House in Multiple Occupation) properties might be profitable. These properties are rental units shared by three or more tenants who aren't from the same household. They offer high rental yields and cater to the growing demand for shared accommodation. Working with an HMO Management Agency [https://hmolettingagent.co.uk/hmo-management/] can streamline the process and ensure compliance with legal requirements. This article will guide you through
Human Milk Oligosaccharides (HMO) Market Insights and Future Outlook
According to a new report published by Allied Market Research, titled, "Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2028,"the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028. 📍𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 @ https://www.alliedmarketresearch.com/request-sample/A12027 💡𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐎𝐟𝐟𝐞𝐫
How Big is Human Milk Oligosaccharides (HMO) Market?
The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 850.5 million by 2030. The market is growing at a CAGR of 20.1% during the forecast period 2024-2031. A new Report by DataM Intelligence, titled "Human Milk Oligosaccharides (HMO) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis
Human Milk Oligosaccharides (HMO) Market Regional Analysis & Forecast
The global Human Milk Oligosaccharides Market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period. The global HMO market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value
Global Human Milk Oligosaccharides (HMO) Market Research Report 2016
This report studies Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Beghin Meiji (France) Beneo-Orafti SA (Belgium) Cargill, Inc. (US) Cosucra Groupe Warcoing SA (Belgium) Ingredion Incorporated (US) Royal Cosun (The Netherlands) Sensus (The Netherlands) Yakult Pharmaceutical Industry Co., Ltd. (Japan) Major Manufacturers of Prebiotic Food Products Abbott Nutrition (US) Clasado BioSciences